The Technical Analyst
Select Language :
Arbutus Biopharma Corp [ABUS]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Arbutus Biopharma Corp Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Arbutus Biopharma Corp is listed at the  Exchange

-0.77% $2.58

America/New_York / 28 mar 2024 @ 16:00


Arbutus Biopharma Corp: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 463.09 mill
EPS: -0.440
P/E: -5.86
Earnings Date: May 01, 2024
SharesOutstanding: 179.49 mill
Avg Daily Volume: 0.962 mill
RATING 2024-03-28
B-
Sell
RATINGS
Rating CashFlow: Strong Sell
Return On Equity: Sell
Return On Asset: Sell
DE: Neutral
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -5.86 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-1.00x
Company: PE -5.86 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 2.48 - 2.68

( +/- 3.84%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-02-01 Naftzger J. Christopher Buy 380 500 Stock Option (Right to Buy)
2024-02-01 Naftzger J. Christopher Buy 95 100 Common Shares
2024-02-01 Sims Karen Buy 403 900 Stock Option (Right to Buy)
2024-02-01 Sims Karen Buy 101 000 Common Shares
2024-02-02 Sims Karen Sell 4 358 Common Shares
INSIDER POWER
90.44
Last 95 transactions
Buy: 35 682 262 | Sell: 1 766 657

Forecast: 16:00 - $2.59

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $2.59
Forecast 2: 16:00 - $2.59
Forecast 3: 16:00 - $2.59
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $2.58 (-0.77% )
Volume 0.510 mill
Avg. Vol. 0.962 mill
% of Avg. Vol 52.99 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Arbutus Biopharma Corp

Last 12 Months

Last 12 months chart data with high, low, open and close for Arbutus Biopharma Corp

RSI

Intraday RSI14 chart for Arbutus Biopharma Corp

Last 10 Buy & Sell Signals For ABUS

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:35sell$2.55N/AActive
Profile picture for
            Arbutus Biopharma Corp

ABUS

Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical trial targeted to hepatocytes that inhibits viral replication and reduces various HBV antigens using novel covalently conjugated N-acetylgalactosamine (GalNAc) delivery technology; and AB-836, an oral capsid inhibitor that suppresses HBV DNA replication. The company's research and development programs include AB-161, an oral HBV RNA destabilizer to destabilize HBV RNA, which leads in the reduction of HBsAg and other viral proteins; AB-101, an oral PD-L1 inhibitor to reawaken patients' HBV-specific immune response; and small molecule antiviral medicines to treat coronaviruses, including COVID-19. It has strategic alliance, licensing, and research collaboration agreements with Talon Therapeutics, Inc.; Gritstone Oncology, Inc.; Alnylam Pharmaceuticals, Inc.; Qilu Pharmaceuticals Co, Ltd.; Assembly Biosciences, Inc.; Acuitas Therapeutics, Inc.; and Antios Therapeutics, Inc. Arbutus Biopharma Corporation also has a clinical collaboration agreement with Vaccitech plc to evaluate a triple combination of AB-729 for the treatment of chronic HBV infection. The company was formerly known as Tekmira Pharmaceuticals Corporation and changed its name to Arbutus Biopharma Corporation in July 2015. Arbutus Biopharma Corporation is headquartered in Warminster, Pennsylvania.

Last 10 Buy Signals

Date Signal @
WEMIXUSDMar 28 - 20:28$2.28
TOMOUSDMar 28 - 20:28$1.120
PROMUSDMar 28 - 20:24$13.92
RENBTCUSDMar 28 - 20:2370 493
LAZIOUSDMar 28 - 20:233.54
ASRUSDMar 28 - 20:243.13
BATUSDMar 28 - 20:21$0.334
RAYUSDMar 28 - 20:18$2.01
MSOLUSDMar 28 - 20:19223.01
NEOUSDMar 28 - 20:18$16.08

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.